Skip to main content
NewslettersWatchlist

Bruker Corp(BRKR-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low54.00
Day High54.00
Open:54.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
GlobeNewswire
Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems
GlobeNewswire
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
GlobeNewswire
Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference
GlobeNewswire
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
Barchart
Stocks Close Lower as Bond Yields Climb
Barchart
Stocks Slide on Higher Bond Yields
Barchart
Stocks Tumble on Concern Interest Rates Will Stay Higher for Longer
GlobeNewswire
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
Barchart
Chart of the Day: Bruker Measures Up
GlobeNewswire
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
GlobeNewswire
Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress
PR Newswire
PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
GlobeNewswire
Biognosys Unveils Innovative Workflow for Deep and Reproducible Plasma Proteomics, Enabling Breakthroughs in Molecular Diagnostics and Drug Development
Business Wire
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
Business Wire
Bruker Reports First Quarter 2023 Financial Results
Business Wire
Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
Business Wire
Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
Business Wire
PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
Business Wire
Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
Business Wire
Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
The Globe and Mail
13 U.S. health care stocks starting to shine again

Profile

Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.